文献

J-GLOBAL ID：201702211973018807   整理番号：17A0016813

幹細胞ソースによって層別化した,移植片対宿主病の予防のためにメトトレキサートと併用したタクロリムスおよびシクロスポリンの比較:後向き全国調査

A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey

著者 (20件)： Sakai Rika (Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan) ,  Taguri Masataka (Department of Biostatistics and Epidemiology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan) ,  Oshima Kumi (Division of Hematology and Oncology, St. Luke International Hospital, Tokyo, Japan) ,  Mori Takehiko (Division of Hematology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan) ,  Ago Hiroatsu (Division of Hematology and Oncology, Shimane Prefectural Central Hospital, Matsue, Japan) ,  Adachi Souichi (Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan) ,  Morita Satoshi (Department of Biostatistics and Epidemiology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan) ,  Taniguchi Shuichi (Department of Hematology, Toranomon Hospital, Tokyo, Japan) ,  Fukuda Takahiro (Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan) ,  Ohashi Kazuteru (Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan) ,  Eto Tetsuya (Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan) ,  Miyamura Koichi (Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan) ,  Iwato Koji (Department of Hematology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan) ,  Kobayashi Naoki (Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan) ,  Kanamori Heiwa (Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan) ,  Morishima Yasuo (Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan) ,  Nagamura-Inoue Tokiko (Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan) ,  Sakamaki Hisashi (Department of Cell Processing and Transfusion, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan) ,  Atsuta Yoshiko (Department of Hematopoietic Stem Cell Transplantation Data Management and Biostatistics, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Murata Makoto (Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan)
資料名： International Journal of Hematology  (International Journal of Hematology)
巻： 103  号： 3  ページ： 322-333  発行年： 2016年03月 
JST資料番号： F0888A  ISSN： 0925-5710  CODEN： IJHEEY  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： この全国後向き研究は,急性移植片対宿主病(aGVHD)予防と...

シソーラス用語： *移植片対宿主病 ,...
準シソーラス用語： *急性移植片対宿主病 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0016813&from=J-GLOBAL&jstjournalNo=F0888A") }}

著者キーワード (4件)： Tacrolimus ,  Cyclosporine ,  Methotrexate ,  Graft-versus-host disease

分類 (2件)： 免疫性疾患・アレルギー性疾患の治療  (GD04030Y) ,  臨床腫よう学一般  (GE03010Y)

物質索引 (3件)： メトトレキサート ,  シクロスポリン ,  タクロリムス

引用文献 (31件)：

• Ratanatharathorn V, Nash RA, Przepiorka D, Devine SM, Klein JL, Weisdorf D, et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood. 1998;92:2303-14.
• Horowitz MM, Przepiorka D, Bartels P, Bartels P, Buell DN, Zhang MJ, et al. Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine. Biol Blood Marrow Transplant. 1999;5:180-6.
• Nash RA, Antin JH, Karanes C, Fay JW, Avalos BR, Yeager AM, et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood. 2000;96:2062-8.
• Hiraoka A, Ohashi Y, Okamoto S, Moriyama Y, Nagao T, Kodera Y, et al. Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 2001;28:181-5.
• Yanada M, Emi N, Naoe T, Sakamaki H, Takahashi S, Hirabayashi N, et al. Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan. Bone Marrow Transplant. 2004;34:331-7.

タイトルに関連する用語 (10件)： 幹細胞 ,  ソース ,  層別化 ,  移植片対宿主病 ,  予防 ,  メトトレキサート ,  併用 ,  タクロリムス ,  シクロスポリン ,  調査